Cancer
Malignant Lung Neoplasm
CI-CAN-00001140Explore in graph →
Top-level2,650 active trials51 approved drugs619 evidence items
- NCIt
- C7377
- ICD-10
- C33-C34
- DOID
- 1324
- Other
- 1 more code
Loading cancer entity…
Cancer
CI-CAN-00001140Explore in graph →
Clinical trials
11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,491)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00085826 | A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients | completed | Phase 3 | 600 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00356122 | Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 53 | SanofiINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01103089 | Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) | completed | — | 10 | AstraZenecaINDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT01442909 | Pemetrexed Followed by Docetaxel or in Reverse Sequence | completed | Phase 4 | 44 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 29, 2011 | clinicaltrials |
| NCT01274858 | Sensory Mapping and Thermal Thresholds After Thoracic Surgery | completed | — | 12 | Rigshospitalet, DenmarkOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00516022 | Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.(Iscador) | completed | Phase 2 | 79 | Rambam Health Care CampusOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00749346 | NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 42 | NovoCure Ltd.INDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00380055 | Reducing Cancer Disparities for American Indians in the Rural Intermountain West | completed | N/A | 1,800 | University of UtahOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT01112631 | Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy | completed | — | 293 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT00686322 | Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) | completed | Phase 4 | 6 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 15, 2011 | clinicaltrials |
| NCT00752115 | Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 120 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00881296 | Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer(GEEP) | completed | Phase 2 | 60 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00213733 | Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer | completed | — | 150 | University Hospital, Strasbourg, FranceOTHER | 1 | Aug 30, 2011 | clinicaltrials |
| NCT00180154 | Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET | completed | — | 50 | Technische Universität DresdenOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 3 | 260 | Eli Lilly and CompanyINDUSTRY | 6 | Aug 10, 2011 | clinicaltrials |
| NCT00862030 | CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer | completed | — | 20 | Alberta Health servicesOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT01185314 | To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)(PIONEER) | completed | N/A | 1,270 | AstraZenecaINDUSTRY | 7 | Aug 8, 2011 | clinicaltrials |
| NCT00115518 | Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 30 | Heidelberg UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00005989 | R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | — | Mayo ClinicOTHER | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00040638 | Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00047801 | Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 28 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00077883 | TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 50 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00708812 | Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 126 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00522886 | Phase I Cetuximab and Concurrent Radio-chemotherapy | completed | Phase 1 | 24 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01282450 | Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00509457 | GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | N/A | 20 | Oslo University HospitalOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00293085 | An Open, Randomized, Multicentre, Phase II Pilot Study | completed | Phase 2 | 37 | Central European Cooperative Oncology GroupOTHER | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00807391 | Transbronchial Catheter Aspiration and Transbronchial Needle Aspiration in the Diagnosis of Lung Cancer | completed | N/A | 48 | Helios Klinik AmbrockOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00055978 | Celecoxib in Preventing Lung Cancer in Former Heavy Smokers | completed | Phase 2 | 112 | University of California, Los AngelesOTHER | 1 | Jun 20, 2011 | clinicaltrials |
| NCT00531401 | Study of Salirasib to Treat Non-Small Cell Lung Cancer | completed | Phase 2 | 71 | Concordia Pharmaceuticals, IncINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC | completed | Phase 2 | 121 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00379782 | Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project | completed | N/A | 628 | Queen's Medical CenterOTHER | 1 | May 30, 2011 | clinicaltrials |
| NCT00614965 | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV | completed | Phase 2 | 124 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00305617 | Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer | completed | N/A | 10 | The Cleveland ClinicOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00193336 | Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | completed | Phase 2 | 34 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT00782366 | Predictive Genetic Risk Assessment Trial(PGT) | completed | — | 26 | Mayo ClinicOTHER | 1 | Apr 27, 2011 | clinicaltrials |
| NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT00602433 | Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib | completed | — | 10 | Northwestern UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00391274 | Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 211 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2011 | clinicaltrials |
| NCT00737867 | Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 444 | The Norwegian Lung Cancer Study GroupNETWORK | 1 | Apr 4, 2011 | clinicaltrials |
| NCT00745160 | Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes | completed | — | 115 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 30, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Oct 20, 2011source: clinicaltrials